| Literature DB >> 29117570 |
Yelena Nersesyan1, Lusine Demirkhanyan1, Deny Cabezas-Bratesco2, Victoria Oakes3, Ricardo Kusuda4, Tyler Dawson1, Xiaohui Sun5, Chike Cao6, Alejandro Martin Cohen7, Bharath Chelluboina1, Krishna Kumar Veeravalli1, Katharina Zimmermann8, Carmen Domene9, Sebastian Brauchi2, Eleonora Zakharian10.
Abstract
Oxytocin is a hormone with various actions. Oxytocin-containing parvocellular neurons project to the brainstem and spinal cord. Oxytocin release from these neurons suppresses nociception of inflammatory pain, the molecular mechanism of which remains unclear. Here, we report that the noxious stimulus receptor TRPV1 is an ionotropic oxytocin receptor. Oxytocin elicits TRPV1 activity in native and heterologous expression systems, regardless of the presence of the classical oxytocin receptor. In TRPV1 knockout mice, DRG neurons exhibit reduced oxytocin sensitivity relative to controls, and oxytocin injections significantly attenuate capsaicin-induced nociception in in vivo experiments. Furthermore, oxytocin potentiates TRPV1 in planar lipid bilayers, supporting a direct agonistic action. Molecular modeling and simulation experiments provide insight into oxytocin-TRPV1 interactions, which resemble DkTx. Together, our findings suggest the existence of endogenous regulatory pathways that modulate nociception via direct action of oxytocin on TRPV1, implying its analgesic effect via channel desensitization.Entities:
Keywords: MD simulations; TRPV1 ion channel; molecular dynamics simulations; nociception; oxytocin; oxytocin receptor; planar lipid bilayers; transient receptor potential vanilloid 1
Mesh:
Substances:
Year: 2017 PMID: 29117570 PMCID: PMC5701661 DOI: 10.1016/j.celrep.2017.10.063
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423